BIBLIOGRAPHIC RECORD

Dual-target mu opioid-dopamine D<sub>3</sub> receptor (MOR-D<sub>3</sub>R) ligands based on etonitazene: New leads for transforming "nitazenes" into novel analgesics.

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Khorshada Jahan; Grant Glatfelter; Julie Sanchez; Alexander D Maitland; Alessandro Bonifazi; Elizabeth Saab; Bradley M Keegan; Rana Rais; Guo-Hua Bi; Juan L Gomez; Michael Michaelides; Zheng-Xiong Xi; J Robert Lane; Meritxell Canals; Michael H Baumann; Amy Hauck Newman
Source of metadata
PubMed
Year recorded
2026

Public identifiers and source

Open the source record

Reference

Khorshada Jahan; Grant Glatfelter; Julie Sanchez; Alexander D Maitland; Alessandro Bonifazi; Elizabeth Saab; Bradley M Keegan; Rana Rais; Guo-Hua Bi; Juan L Gomez; Michael Michaelides; Zheng-Xiong Xi; J Robert Lane; Meritxell Canals; Michael H Baumann; Amy Hauck Newman. (2026). Dual-target mu opioid-dopamine D<sub>3</sub> receptor (MOR-D<sub>3</sub>R) ligands based on etonitazene: New leads for transforming "nitazenes" into novel analgesics. https://pubmed.ncbi.nlm.nih.gov/42361479/

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.